RxDoctor Payments Data

Neal Rakesh, MD

Pain Medicine · New York, NYNPI 1902254030

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (50.9%), grants and speaking fees — rather than concentrated in one kind of arrangement. Medtronic accounts for 72.2% of it on its own, with 9 other manufacturers making up the rest. Among pain medicine clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$16,020in general payments, 2019–2025

Across 119 payments — averaging $134.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$12K
  • Boston Scientific$1K
  • SPR Therapeutics, Inc$1K
  • Stratus Medical, LLC$408
  • Shimadzu Precision Instruments, Inc.$395
  • Rivanna Medical, Inc$350
  • plus $896 from 4 others

What the payments were for

  • Consulting fees$3502%
  • Speaking & faculty fees$1,5009%
  • Grants$4,42728%
  • Travel & lodging$1,1967%
  • Food & beverage$8,15151%
  • Entertainment$3952%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)84$11,560
Boston Scientific12$1,393
SPR Therapeutics, Inc10$1,017
Stratus Medical, LLC3$408
Shimadzu Precision Instruments, Inc.1$395
Rivanna Medical, Inc1$350
Nalu Medical, Inc.2$320
Nevro Corp.4$279
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC1$266
AbbVie1$30

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,020 in reported general payments places this provider in the 90th percentile of 503 pain medicine providers in New York.

See all pain medicine providers in New York

Medicare billing

Part B allowed, 2024
$69,982
Medicare patients
310
Services billed
716

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin39$1,330
Fentanyl17$1,232
Gabapentin89$975
Oxycodone Hcl81$920
Tizanidine Hcl59$723
Baclofen21$387
Duloxetine Hcl34$288
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen17$194
Hydromorphone Hcl11$139
Tramadol Hcl14$93

Paid to pharmacies, not to this prescriber.

Other pain medicine in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →